Portfoliotracker

Embecta Corp.

EMBC · NASDAQGS · Healthcare Medical Instruments & Supplies 50/100 C

6,250 $
▼ −0,210 (−3,25 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 13:22
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score50 / 100 Market cap366 mil. $ P/E4,3 Forward P/E3,5 P/S0,4 P/B– EV/EBITDA6,0 Dividend yield5,12 % FCF yield45,01 % EPS1,47 $ Net margin8,6 % Return on equity– Beta0,81 Debt / equity–
52-week range 2,77 to 14,81
3-month average volume1,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Employees
1 850
Country
United States
Fiscal year end
30. 9.
Data since
22. 3. 2022

Explore further

Similar companies AZTAVREXTMCIENOVBLCO

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account